We'd like to call this meeting to order. We have our witnesses with us for this hour panel. We're continuing the study on the Trans-Pacific Partnership.
We have with us the Centre for Drug Research and Development, Ms. Es Sabar. Thank you for being with us.
From OpenMedia.ca—and I'm not exactly sure, but I'm sure I'll find out what that's all about—we have Mr. Anderson.
Thank you very much for being here.
We'll start with Ms. Es Sabar. The floor is yours.